Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology

• Sponsor: University Hospital, Ghent (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT00313989
• Collaborator: (none)
• Enrollment: 200
• Location: 1
• Arm: 1
• Duration (Months): 95
• Patients Per Site Per Month: 2.1

Study Details

Study Description

Brief Summary

Follow up of implants with patients receiving radiotherapy for buccopharyngeal oncology. Implants will be placed 6 weeks before start of the radiotherapy or at least 3 months after the end of the radiotherapy

Condition or Disease	Intervention/Treatment	Phase
Dental Implants	Procedure: Evaluation of the success rate of implants	N/A

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 200 participants
• Allocation: Non-Randomized
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology
• Study Start Date: Sep 1, 2007
• Anticipated Primary Completion Date: Aug 1, 2015
• Anticipated Study Completion Date: Aug 1, 2015

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Evaluation of implants of patients receiving radiotherapy.	Procedure: Evaluation of the success rate of implants; Evaluation of the success rate of implants

Outcome Measures

Primary Outcome Measures

1. Recovering and ingrowing of dental implants [4 to 6 months]

2. Success rate of dental implants [4 to 6 months]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Patients receiving radiotherapy (6 weeks later or at least 3 months before) for buccopharyngeal oncology

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University Hospital Ghent	Ghent		Belgium	9000

Sponsors and Collaborators

• University Hospital, Ghent

Investigators

• Principal Investigator: Hugo De Bruyn, MD, PhD, University Hospital, Ghent

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

• Website University Hospital Ghent

Publications

None provided.

• Responsible Party: University Hospital, Ghent
• ClinicalTrials.gov Identifier: NCT00313989
• Other Study ID Numbers: 2006/125
• First Posted: Apr 12, 2006
• Last Update Posted: Dec 5, 2014
• Last Verified: Dec 1, 2014

Study Results

No Results Posted as of Dec 5, 2014